Clinical trials
Recruiting Prostatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
987 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 7 |
| 2015 | 10 |
| 2016 | 11 |
| 2017 | 9 |
| 2018 | 18 |
| 2019 | 31 |
| 2020 | 29 |
| 2021 | 59 |
| 2022 | 64 |
| 2023 | 121 |
| 2024 | 191 |
| 2025 | 213 |
| 2026 | 201 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 987 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 21 |
| M.D. Anderson Cancer Center | 17 |
| Mayo Clinic | 17 |
| Memorial Sloan Kettering Cancer Center | 15 |
| Chinese University of Hong Kong | 14 |
| Jonsson Comprehensive Cancer Center | 14 |
| University Health Network, Toronto | 13 |
| AstraZeneca | 12 |
| City of Hope Medical Center | 11 |
| Institute of Cancer Research, United Kingdom | 10 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 987 |
| Breast Neoplasms | 97 |
| Neoplasms | 59 |
| Ovarian Neoplasms | 53 |
| Colorectal Neoplasms | 51 |
| Lung Neoplasms | 51 |
| Adenocarcinoma | 47 |
| Pancreatic Neoplasms | 43 |
| Neoplasm Metastasis | 42 |
| Disease | 37 |
Trials
Showing 51 to 75 of 987. Each trial links to its page on Pharma Observatory.
887 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.